Company Profile
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Latest News

3 Overrated Stocks We Think Twice About
Barclays Upgrades Fortrea to Overweight From Equalweight

Fortrea (FTRE) Stock Trades Up, Here Is Why
Barclays Upgrades Fortrea Holdings to Overweight From Equalweight

2 Volatile Stocks to Consider Right Now and 1 We Find Risky

Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call
Related stocks
Key Metrics & Overview
Detailed metrics & financial data of the company
🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data